BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 17426248)

  • 1. Integrative genomic analysis of small-cell lung carcinoma reveals correlates of sensitivity to bcl-2 antagonists and uncovers novel chromosomal gains.
    Olejniczak ET; Van Sant C; Anderson MG; Wang G; Tahir SK; Sauter G; Lesniewski R; Semizarov D
    Mol Cancer Res; 2007 Apr; 5(4):331-9. PubMed ID: 17426248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell lines.
    Coe BP; Lee EH; Chi B; Girard L; Minna JD; Gazdar AF; Lam S; MacAulay C; Lam WL
    Genes Chromosomes Cancer; 2006 Jan; 45(1):11-9. PubMed ID: 16130125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
    Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
    Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer.
    Kang JU; Koo SH; Kwon KC; Park JW; Kim JM
    Cancer Genet Cytogenet; 2008 Apr; 182(1):1-11. PubMed ID: 18328944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic characterization of NCI-H69 and NCI-H69AR small cell lung cancer cell lines by spectral karyotyping.
    Salido M; Arriola E; Carracedo A; Cañadas I; Rovira A; Espinet B; Rojo F; Arumi M; Serrano S; Albanell J; Sole F
    Cancer Genet Cytogenet; 2009 Jun; 191(2):97-101. PubMed ID: 19446745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines.
    Coe BP; Henderson LJ; Garnis C; Tsao MS; Gazdar AF; Minna J; Lam S; Macaulay C; Lam WL
    Genes Chromosomes Cancer; 2005 Mar; 42(3):308-13. PubMed ID: 15611929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated analysis of expression and genome alteration reveals putative amplified target genes in esophageal cancer.
    Sugimoto T; Arai M; Shimada H; Hata A; Seki N
    Oncol Rep; 2007 Aug; 18(2):465-72. PubMed ID: 17611672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
    Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
    Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression profiling reveals distinct expression patterns for Classic versus Variant Merkel cell phenotypes and new classifier genes to distinguish Merkel cell from small-cell lung carcinoma.
    Van Gele M; Boyle GM; Cook AL; Vandesompele J; Boonefaes T; Rottiers P; Van Roy N; De Paepe A; Parsons PG; Leonard JH; Speleman F
    Oncogene; 2004 Apr; 23(15):2732-42. PubMed ID: 14755241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic profiling of malignant pleural mesothelioma with array-based comparative genomic hybridization shows frequent non-random chromosomal alteration regions including JUN amplification on 1p32.
    Taniguchi T; Karnan S; Fukui T; Yokoyama T; Tagawa H; Yokoi K; Ueda Y; Mitsudomi T; Horio Y; Hida T; Yatabe Y; Seto M; Sekido Y
    Cancer Sci; 2007 Mar; 98(3):438-46. PubMed ID: 17270034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of overexpressed genes in frequently gained/amplified chromosome regions in multiple myeloma.
    Largo C; Alvarez S; Saez B; Blesa D; Martin-Subero JI; González-García I; Brieva JA; Dopazo J; Siebert R; Calasanz MJ; Cigudosa JC
    Haematologica; 2006 Feb; 91(2):184-91. PubMed ID: 16461302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
    Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
    Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase II alpha subunit and C1-inhibitor are independent predictors of outcome in patients with squamous cell carcinoma of the lung.
    O-charoenrat P; Rusch V; Talbot SG; Sarkaria I; Viale A; Socci N; Ngai I; Rao P; Singh B
    Clin Cancer Res; 2004 Sep; 10(17):5792-803. PubMed ID: 15355908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution single-nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines.
    Jänne PA; Li C; Zhao X; Girard L; Chen TH; Minna J; Christiani DC; Johnson BE; Meyerson M
    Oncogene; 2004 Apr; 23(15):2716-26. PubMed ID: 15048096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.
    Lombardi L; Poretti G; Mattioli M; Fabris S; Agnelli L; Bicciato S; Kwee I; Rinaldi A; Ronchetti D; Verdelli D; Lambertenghi-Deliliers G; Bertoni F; Neri A
    Genes Chromosomes Cancer; 2007 Mar; 46(3):226-38. PubMed ID: 17171682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression.
    Garnis C; Davies JJ; Buys TP; Tsao MS; MacAulay C; Lam S; Lam WL
    Oncogene; 2005 Jul; 24(30):4806-12. PubMed ID: 15870700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.
    Hurst CD; Fiegler H; Carr P; Williams S; Carter NP; Knowles MA
    Oncogene; 2004 Mar; 23(12):2250-63. PubMed ID: 14968109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.